Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
| Autor: | Köhne, C.-H. *, De Greve, J., Hartmann, J.T., Lang, I., Vergauwe, P., Becker, K., Braumann, D., Joosens, E., Müller, L., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H.-J., Bleiberg, H., Van Den Brande, J., Debois, M., Bethe, U., Van Cutsem, E. |
|---|---|
| Zdroj: | In Annals of Oncology May 2008 19(5):920-926 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|